American Medical Association
Dr. Roger T. Adler currently serves as a clinical ophthalmologist with Bond Eye Associates in Peoria, Illinois. There, he treats a number of different eye-related conditions. As an active member of his professional community, Dr. Roger T. Adler is a member of the American Medical Association (AMA).
The American Medical Association recently released a newly updated version of its Code of Medical Ethics. This new edition represents the culmination of an eight-year effort to bring the guidelines in line with contemporary medical policies, practices, and technologies. The book is currently available in both print and digital editions from the AMA’s website.
The foundational resource for physicians, students, and other medical professionals, the Code of Medical Ethics was first released in 1847. It has been the bedrock ethics publication in the field of medicine ever since. Throughout its 170 year existence, the book has been referenced by legal professionals, medical journals, and media organizations as the definitive guide for best medical practices.
American Society of Retina Specialists
An ophthalmologist and retina specialist, Dr. Roger T. Adler has worked in the field of medicine for more than 20 years. In addition to serving as a doctor at Bond Eye Associates offices in Peoria, Pekin, and Canton, Illinois, Dr. Roger T. Adler is a member of many professional associations including the American Society of Retina Specialists.
The largest organization of its kind, the ASRS is a community of close to 3,000 retina specialists across the United States and around the world. The association is dedicated to expanding research and education opportunities for doctors and advocating for beneficial legislation. One of the society’s many advocacy campaigns included a fight to gain greater access for eye specialists to the drug Avastin, the trade name for the medication bevacizumab.
A 2012 outbreak of fungal meningitis complicated patient access to this drug, which has been found effective for conditions such as age-related macular degeneration. The campaign resulted in the collection of hundreds of letters from ASRS members recommending the Food and Drug Administration (FDA) extend the recently shortened beyond-use dates of “repackaged” bevacizumab; the ASRS argued this restriction by the FDA makes the drug unobtainable for many retina specialists and their patients.
In January, 2017, a revised version of the FDA document pertaining to this matter was released which indicated a step in favor of the ASRS argument – the allowable beyond-use date had been extended.
Dr. Roger T. Adler is an ophthalmologist with Bond Eye Associates, a clinic comprised of three offices in and around Peoria, Illinois. A graduate of the Chicago Medical School, Dr. Roger T. Adler specializes in retinal surgery, and is an expert in the diagnosis and treatment of the retina, including vitreous and macular diseases and conditions such as macular degeneration, retinopathy, and ocular inflammation.
– Macular Degeneration: The primary cause of vision loss, macular degeneration is most often seen in older patients (age-related macular degeneration or AMD), and occurs when the center of the retina – the macula – begins to degrade. This part of the eye is critical to clear vision, and enables people to carry out tasks such as reading, driving, and recognizing colors.
– Retinopathy: Often seen in individuals with type 1 or type 2 diabetes, retinopathy occurs when blood vessels in the retina incur damage. Though initially this condition may affect vision only slightly, it can eventually lead to blindness. Symptoms of retinopathy include seeing floating spots, dark or “empty” areas, and experiencing blurred vision.
– Ocular Inflammation: Ocular inflammatory disease (OID) refers to any inflammation of the eye or the tissues surrounding the eye, including the optic nerve, blood vessels, and muscles. This disease can be caused by an infection or an existing inflammatory disorder, and can lead to glaucoma or cataracts.
Bond Eye Associates
Over the course of his career, ophthalmologist Dr. Roger T. Adler has developed and refined his expertise as a retinal specialist. As part of Bond Eye Associates, Dr. Roger Adler routinely treats cases of macular degeneration.
Macular degeneration stands out as the most common cause of vision loss in the United States today. More prevalent than glaucoma and cataracts combined, the condition occurs when the central area of the retina deteriorates.
Located in the rear of the eye, the retina is responsible for translating visual information into neurological signals. The term macula refers to the retina’s central area, and thus processes all functions of central vision, including those that allow a person to see detail and recognize colors.
When central vision breaks down, the patient may experience blurriness or distortion in the center of the visual field while peripheral vision remains clear.
Most patients experience what is known as dry or atrophic macular degeneration. Usually a result of aging, it most often develops when the macular tissues thin and deposits of protein form underneath the retina. Patients with this condition typically notice gradual vision loss.
The vision loss of dry macular degeneration is typically less severe than that involved in the wet, or exudative, form. This affects approximately 10 percent of patients with macular degeneration and results from the growth of abnormal blood vessels below the retina. These abnormally formed vessels can then leak and cause a rapid decline in central vision.
Experts urge patients who experience blurriness or distortion in the central vision realm to consult with an ophthalmologist. In some cases, a schedule of vitamins can help to mitigate the condition’s effects.